Home/Filings/4/0001213900-25-091099
4//SEC Filing

MARTELL RON 4

Accession 0001213900-25-091099

CIK 0001788028other

Filed

Sep 23, 8:00 PM ET

Accepted

Sep 24, 4:01 PM ET

Size

7.3 KB

Accession

0001213900-25-091099

Insider Transaction Report

Form 4
Period: 2025-09-22
MARTELL RON
DirectorPresident, CEO and Director
Transactions
  • Purchase

    Common Stock Warrant (right to buy)

    2025-09-22+41,00041,000 total
    Exercise: $2.92From: 2026-03-22Exp: 2030-03-22Voting Common Stock (41,000 underlying)
  • Purchase

    Voting Common Stock

    2025-09-22$2.43/sh+41,000$99,63074,118 total
Footnotes (1)
  • [F1]Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.

Documents

1 file

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1
  • filerCIK 0001177079

Filing Metadata

Form type
4
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 4:01 PM ET
Size
7.3 KB